Western Alliance Bancorporation (WAL): WAl IS CLOSING GAP

Play Episode

7min

Proactive - Interviews for investors

TNR Gold chair welcomes progress at McEwen Copper's Los Azules copper project in Argentina

TNR Gold Corp (TSX-V:TNR, OTC:TRRXF) executive chairman Kirill Klip talked with Proactive's Stephen Gunnion about the company’s latest developments, including a key milestone in its transition to a cash-flow-generating royalty business. Klip highlighted that TNR Gold holds royalties on significant projects, including the Los Azules Copper project and the Mariana Lithium project in Argentina. With Los Azules now applying for Argentina's incentive regime for large investments, he explained that the project could see substantial tax reductions, making it easier to attract the $2.7 billion investment required for construction. Discussing Argentina’s economic reforms under President Javier Milei, Klip noted that the country's policies are encouraging large-scale investment in the mining sector. He also pointed to the environmental permit secured for Los Azules, bringing it closer to a construction decision, with a feasibility study expected in the first half of the year. Klip also shared insights from Fundamental Research Corporation’s latest analysis, which increased its price target for TNR Gold from $0.24 to $0.28, underscoring the company's transition from a project generator to a cash-flow-generating royalty company. Watch the full interview for more insights into TNR Gold’s latest developments. For more interviews like this, subscribe to Proactive’s YouTube channel, give this video a like, and turn on notifications for future updates! #TNRGold #MiningInvesting #LosAzules #CopperMining #LithiumInvesting #MiningStocks #ArgentinaMining #RoyaltyCompany #StockMarket #JavierMilei

Proactive - Interviews for investors

Wedgemount Resources updates field activities at Huggy Assets, reactivates five wells

Wedgemount Resources CEO Mark Vanry joined Steve Darling from Proactive to provide an update to Proactive on the company's field activities at its recently acquired Huggy Assets. After weather-related delays, Wedgemount has full operations going, including pumping, surface facility optimization, maintenance, chemical treatments, and well workovers. The company's primary focus remains on the Echo and Novice operational areas, where five additional wells have been brought back online. These wells had been inactive for a significant period before Wedgemount's acquisition. Historical initial production (IP) rates for these wells ranged from 15 to 65 barrels of oil equivalent per day (boepd). Vanry noted that previous successful chemical stimulations on Wedgemount’s Willowbend leases resulted in improved well performance. The company expects similar or better results from workovers and chemical treatments at Huggy, potentially exceeding the original IP rates. Looking ahead, Wedgemount has over 100 additional wells that have yet to undergo chemical stimulation, presenting significant production upside over the next two years. #proactiveinvestors #westmountreosurcescorp #cse #wdgy #otcqb #wdgrf #OilProduction #TexasEnergy #EnergyInvesting #OilandGas #MarkVanry #ProactiveInvestors #EnergyStocks #Investing #OilExploration

Proactive - Interviews for investors

Clinical study SKNJCT-003 shows positive trends as company advances skin cancer research in UAE

Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to share updates on the ongoing SKNJCT-003 clinical study, which is being conducted at nine sites across the United States and aims to randomize 60 patients. An interim analysis conducted after enrolling more than half of the targeted participants has shown encouraging results. The study reports a clinical clearance rate exceeding 60%, with the investigational therapy demonstrating strong tolerability across both tested dosage levels. Notably, no dose-limiting toxicities (DLTs) or serious adverse events (SAEs) have been observed, and there have been no systemic effects or clinically significant abnormalities in laboratory results, ECGs, vital signs, or physical exams. These promising findings will be submitted to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025. In parallel, the company is advancing its clinical initiatives for non-invasive basal cell carcinoma treatment with a newly proposed study. This randomized, double-blind, placebo-controlled, multi-center trial has been submitted for approval to the UAE Department of Health. The study aims to enroll up to 36 patients at prominent medical institutions, including Cleveland Clinic Abu Dhabi, Sheikh Shakbout Medical City, Burjeel Medical City, and the American Hospital of Dubai. Participants will be assigned in a 1:1:1 ratio to receive either a placebo or one of two dosage levels of the experimental treatment. This expansion into the UAE represents a significant step forward in the company’s mission to develop innovative, non-invasive therapies for skin cancer, broadening its global clinical footprint and reinforcing its commitment to advancing patient care. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch

Proactive - Interviews for investors

Blockmate Ventures: Hivello’s AI expansion with Nosana

Blockmate Ventures Inc (TSX-V:MATE, OTCQB:MATEF) chairman Domenic Carosa talked with Proactive's Stephen Gunnion about Hivello’s latest integration with the Nosana network. Carosa explained that Hivello allows users to rent out their computer resources, similar to how AirBnB operates for homes. This model enables users to generate passive income while contributing to a decentralized blockchain network. The integration with Nosana enhances this model by tapping into AI demand. “Nosana is one of the leading GPU DePINs… they basically power AI,” Carosa said. He highlighted that Hivello’s users are now actively contributing to training AI models and earning from it. Carosa also discussed the recent token generation event (TGE), comparing it to an IPO in the crypto space. As of the interview, Hivello’s token had a fully diluted value of over $20 million, providing significant value to Blockmate Ventures, which owns approximately 50% of Hivello. Looking ahead, Blockmate Ventures is focused on expanding its DePIN integrations and increasing customer adoption. Carosa emphasized that the company is doubling down on AI and blockchain opportunities in 2025. For more exclusive interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and turn on notifications for the latest insights! #BlockmateVentures #Hivello #Nosana #AI #DePIN #Crypto #Blockchain #TokenGeneration #Web3 #PassiveIncome #TechInvesting

Followers	5
Posts	1163
Boards Moderated	0
Alias Born	04/15/2014

Volume:	1,098,765
Day Range:	76.50 - 78.04
Bid:
Ask:
Last Trade Time:	7:00:00 PM EDT
Total Trades:	18,950

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

WAL Detailed Quote

Recent WAL News

More WAL News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent WAL News

Go Ad-Free